focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: K3 director linked to purchase, Diurnal exec sells shares into ISA

Mon, 09th May 2022 14:01

(Sharecast News) - Software company K3 Business Technology was at the top of the list of buys on Monday, after Kestrel Partners spent more than £40k on its shares.

The AIM-traded firm said Kestrel Partners, on behalf of its discretionary clients, bought 27,129 shares for 150p each, spending a total of £40,693.50.

Its non-executive director Oliver Scott is a partner of, and holds a beneficial interest in Kestrel, and is also a shareholder in one of Kestrel's clients, Kestrel Opportunities, and so has a beneficial interest in Kestrel Opportunities' entire legal holding in the company.

Following the purchase, K3 said Kestrel Opportunities held 8,515,879 of its shares, and other clients of Kestrel in which Scott had no beneficial interest held 2,775,101 shares.

In total, Kestrel indirectly held voting rights over 11,290,980 of K3's shares, representing 25.24% percent of its issued share capital.

On the selling side of the ledger, specialty pharmaceutical company Diurnal Group disclosed a sale worth over £40k made by its chief scientific officer.

The AIM-traded firm said Richard Ross sold 312,000 shares for 13p each, while his and his wife's individual savings accounts (ISAs) purchased 153,500 and 153,500 shares, respectively, at a price of 13.01p each.

Following the transactions, the total beneficial interest of Richard Ross and his connected parties was 2,257,155 shares, representing 1.33% of Diurnal's total voting rights as of 9 May.

Top Director Buys

K3 Business Technology Group (KBT)

Director name: Scott,Oliver Rupert Andrew

Amount purchased: 27,129 @ 150.00p

Value: £40,693.50

Diurnal Group (DNL)

Director name: Ross,Richard

Amount purchased: 153,500 @ 13.01p

Value: £19,970.35

Diurnal Group (DNL)

Director name: Ross,Richard

Amount purchased: 153,500 @ 13.01p

Value: £19,970.35

Discoverie Group (DSCV)

Director name: Watson ,Clive

Amount purchased: 2,875 @ 690.00p

Value: £19,837.50

Henderson Smaller Companies Inv Trust (HSL)

Director name: Carter,Kevin

Amount purchased: 1,500 @ 868.36p

Value: £13,025.39

Target Healthcare Reit Ltd (THRL)

Director name: Fyfe,Alison

Amount purchased: 10,000 @ 109.80p

Value: £10,980.00

Mgc Pharmaceuticals Limited Npv (di) (MXC)

Director name: Zomer,Roby

Amount purchased: 819,672 @ 1.30p

Value: £10,655.74

Parity Group (PTY)

Director name: Johns,Mike

Amount purchased: 139,082 @ 7.19p

Value: £10,000.00

Mondi (MNDI)

Director name: Strank,Angela

Amount purchased: 628 @ 1,579.95p

Value: £9,922.08

Henderson Smaller Companies Inv Trust (HSL)

Director name: Freer,Penelope Anne

Amount purchased: 1,000 @ 878.92p

Value: £8,789.20

Reach (RCH)

Director name: Panayi,Barry

Amount purchased: 3,979 @ 124.72p

Value: £4,962.77

Capita (CPI)

Director name: Murphy,Joseph

Amount purchased: 643 @ 26.83p

Value: £172.52

Capita (CPI)

Director name: Lewis,Jonathan (Jon)

Amount purchased: 643 @ 26.83p

Value: £172.52

Capita (CPI)

Director name: Weller,Tim

Amount purchased: 643 @ 26.83p

Value: £172.52

Assura (AGR)

Director name: Cottam,Jayne

Amount purchased: 228 @ 66.16p

Value: £150.84

Assura (AGR)

Director name: Murphy,Jonathan

Amount purchased: 228 @ 66.16p

Value: £150.84

Top Director Sells

Rolls-royce Holdings (RR.)

Director name: East,Warren

Amount sold: 210,515 @ 83.78p

Value: £176,369.47

Diurnal Group (DNL)

Director name: Ross,Richard

Amount sold: 312,000 @ 13.00p

Value: £40,560.00

More News
21 Apr 2021 17:59

TRADING UPDATES: Diurnal taps GBP20 million; Victoria buys new assets

TRADING UPDATES: Diurnal taps GBP20 million; Victoria buys new assets

Read more
15 Apr 2021 19:37

TRADING UPDATES: HSBC announces redemption of US dollar securities

TRADING UPDATES: HSBC announces redemption of US dollar securities

Read more
26 Mar 2021 14:36

TRADING UPDATES: Renew to buy J Browne; Idox in good start to year

TRADING UPDATES: Renew to buy J Browne; Idox in good start to year

Read more
23 Feb 2021 16:23

Alkindi sales drive revenue higher for Diurnal

(Sharecast News) - Speciality pharmaceuticals company Diurnal reported 6% growth in first-half total revenue in its interim results on Tuesday, to £1.21m.

Read more
23 Feb 2021 12:28

UPDATE: Diurnal Loss Widens In First Half; Signs Chronocort Deal

UPDATE: Diurnal Loss Widens In First Half; Signs Chronocort Deal

Read more
23 Feb 2021 12:15

Diurnal Reports Widened Loss In First Half Despite Revenue Growth

Diurnal Reports Widened Loss In First Half Despite Revenue Growth

Read more
16 Feb 2021 15:58

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
27 Jan 2021 09:22

Diurnal Inks Licence Agreement For Alkindi With Citrine Medicine

Diurnal Inks Licence Agreement For Alkindi With Citrine Medicine

Read more
14 Jan 2021 19:15

UK TRADING UPDATE SUMMARY: DWF Sets Up New Global Operating Structure

UK TRADING UPDATE SUMMARY: DWF Sets Up New Global Operating Structure

Read more
14 Jan 2021 15:18

IN BRIEF: Diurnal Pleased With Alkindi Sales In First Half

IN BRIEF: Diurnal Pleased With Alkindi Sales In First Half

Read more
13 Jan 2021 14:36

IN BRIEF: Diurnal Inks Turkey Distribution Deal For Alkindi, Chronocort

IN BRIEF: Diurnal Inks Turkey Distribution Deal For Alkindi, Chronocort

Read more
12 Jan 2021 19:12

IN BRIEF: Diurnal Submits Application To UK Regulators For Chronocort

IN BRIEF: Diurnal Submits Application To UK Regulators For Chronocort

Read more
11 Jan 2021 13:22

IN BRIEF: Diurnal Inks European Patent For Chronocort

IN BRIEF: Diurnal Inks European Patent For Chronocort

Read more
20 Nov 2020 18:03

IN BRIEF: Diurnal Secures Grant Of European Patent For Alkindi

IN BRIEF: Diurnal Secures Grant Of European Patent For Alkindi

Read more
20 Nov 2020 12:04

Diurnal gets European patent for 'Alkindi'

(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced the grant of a patent for 'Alkindi', or hydrocortisone granules in capsules for opening, by the European Patent Office on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.